Controlled release drug products are gaining importance in the pharmaceutic
al industry. Impregnation via supercritical fluids is a potential technique
for the production of these products. The solubilities of the drugs in sup
ercritical carbon dioxide are being measured, since they control the amount
of drug component that can be carried by the mobile phase and therefore th
e impregnation period and extent. The solubilities of 5-fluorouracil and be
ta -estradiol, used in chemotherapy and estrogen hormone therapy, respectiv
ely, are measured at pressures ranging from 100 bar to 220 bar and at 308 K
to 328 K. These drugs have mass fraction solubilities of the order 10(-6)
to 10(-4), which are high enough to make the supercritical impregnation pro
cess a feasible alternative to impregnation employing organic solvents. The
solubilities are presented as a function of solvent density and indicate h
igher solubilities at higher temperatures for both of the drugs. Solubiliti
es of beta -estradiol are also reported at select conditions with ethanol a
s a cosolvent.